Venkata K. Yellepeddi, PhD, RPh

Research Interests

  • Pediatric formulations
  • Pediatric pharmacokinetic modeling
  • Nanotechnology for cancer diagnosis and treatment
  • Non-Viral Gene/Nucleic Acid Delivery
  • Pharmacokinetics of nanotechnology-based formulations
  • Oral Delivery
  • Formulation and stability studies for compounded formulations
  • Active learning strategies for teaching pharmaceutics and pharmacokinetics

Languages

  • English
  • Hindi
  • Telugu

Academic Information

  • Departments: Pediatrics - Research Associate Professor, Pharmaceutics and Pharmaceutical Chemistry - Adjunct Assistant Professor
  • Divisions: Pediatric Clinical Pharmacology

Academic Office Information

  • 801-213-0701
  • Williams Building
    Department of Pediatrics
    295 Chipeta Way, Room: 1S132
    Salt Lake City, UT 84108

Academic Bio

Dr. Yellepeddi is Research Associate Professor in the Division of Clinical Pharmacology, Department of Pediatrics, University of Utah. Dr. Yellepeddi is an Adjunct Assistant Professor at the Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, University of Utah.

Dr. Yellepeddi’s research interests include the development of age-appropriate pediatric formulations and model informed pediatric drug development. He is currently working on research projects involving the development of a nasal formulation for the treatment of pediatric migraine and oral formulation for the postnatal therapy of cerebral palsy. His future research projects include Physiologically Based Pharmacokinetic (PBPK) modeling in pediatrics and development of in vitro models simulating microenvironments of various pediatric organs in normal and disease conditions. In addition, he is interested in the pharmacokinetics of nanotechnology-based therapeutics for the treatment of various disease conditions.

Dr. Yellepeddi is a licensed pharmacist in the State of Utah and advises pharmacists and pharmacy students on clinical pharmacology and compounding sterile and nonsterile dosage forms. Dr. Yellepeddi is a former chair of the American Association of Pharmaceutical Sciences, Rocky Mountain Discussion Group and item-writer for the National Association of Boards of Pharmacy (NABP). His teaching interests include drug development for medical students, basic and clinical pharmacokinetics, and formulation and drug delivery for pediatrics and adults.

Education History

Type School Degree
Fellowship Division of Clinical Pharmacology, Department of Pediatrics, University of Utah
Clinical Pharmacology
Fellow
Certification David Eccles School of Business, University of Utah
Health Science Leadership Development Program
Certificate
Doctoral Training Texas A&M Health Science Center
Major: Medical Sciences; Specialization: Pharmaceutics & Drug Delivery
Ph.D.
Research Fellow Indian Institute of Chemical Technology
Pharmaceutics, Drug Delivery, Pharmacokinetics, Pharmacology & Toxicology
Senior Research Fellow
Undergraduate Kakatiya University
Pharmaceutics
B.Pharm

Global Impact

Education History

Type School Degree Country
Research Fellow Indian Institute of Chemical Technology
Pharmaceutics, Drug Delivery, Pharmacokinetics, Pharmacology & Toxicology
Senior Research Fellow India
Undergraduate Kakatiya University
Pharmaceutics
B.Pharm India

Selected Publications

Journal Article

  1. Burrows AC, Yellepeddi VK, Snyder S, Wakefield M, Jackson D, Huynh J, Nguyen K, Sayre CL (2019). Development and Validation of a Stability-indicating High-performance Liquid Chromatographic Method for Quantification of Progesterone in Compounded Glycerinated Gelatin Troches. Int J Pharm Compd, 23(4), 340-350.
  2. Sayre CL, Cox C, Velazquez G, Le MT, Nguyen AH, Ramos M, Burrows A, Yellepeddi VK (2019). Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets. Int J Pharm Compd, 23(1), 62-64.

Review

  1. Yellepeddi VK, Joseph A, Nance E (). Pharmacokinetics of Nanotechnology-Based Formulations in Pediatric Populations. [Review]. Adv Drug Deliv Rev.

Patent

  1. Yellepeddi VK (2018). Preservative-free prochlorperazine nasal spray for migraine therapy. U.S. Patent No. US 20180344720A1. Washington, D.C.:U.S. Patent and Trademark Office.